ArticleScience translational medicine2022

Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis.

Tiffany Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.